Bio-Rad Laboratories | BIO - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.12B 214M 2026-03
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 2.44B 67M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Danaher USD 52.58B 368M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Merck USD 41.93B 3.94B 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
OraSure Technologies USD 317.78M 4.45M 2026-06
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Roche Holding CHF 32.69B 1.11B 2026-06
Siemens EUR 68.26B 3.87B 2026-06
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tosoh JPY 841.22B 9.43B 2026-06
Waters USD 15.29B 12.73B 2026-03